Cardinal Health ( (CAH) ) just unveiled an announcement.
On March 7, 2025, Cardinal Health’s Board of Directors elected Robert W. Musslewhite and Sudhakar Ramakrishna as independent directors. Musslewhite, with a background in healthcare analytics, and Ramakrishna, an expert in technology and cybersecurity, are expected to bring valuable insights to the board. This strategic move aims to enhance Cardinal Health’s capabilities in navigating complex business environments and driving innovation.
More about Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products, a global manufacturer and distributor of medical and laboratory products, a supplier of home-health and direct-to-patient products and services, an operator of nuclear pharmacies and manufacturing facilities, and a provider of performance and data solutions.
YTD Price Performance: 7.42%
Average Trading Volume: 2,375,948
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $30.56B
See more data about CAH stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com